Little Chat with MTFB's PR chap14 Mar 2019 21:57
I had a brief conversation with the PR chap at MTFB today via email. Apologies if it is boring but maybe there are some lines to be read between. I've put Paul's name in as it is publicly listed in press releases of MTFB and there is nothing private in the exchange. Here it is:
Hi, I am an investor in Motif Bio and would like to know: has a date been arranged for the FDA follow up meeting to the CRL?
As I understand it, the FDA has to respond within 2 weeks of a request for a follow up meeting.
Many thanks,
Waccy Baccy
Hi Waccy,
Thanks for your email.
Motif is proceeding as previously announced to meet and discuss with FDA the Complete Response Letter that the company received. Motif will notify the market once the Company has confirmed the path forward. There isn't any other information that we can provide at the moment but we'd be happy to add you to our distribution list for Motif Bio so you are emailed any updates as they go out.
Kind regards,
Paul McManus
Walbrook PR Ltd
Hi there, yes please add me onto your distribution list. Shame you aren't allowed to at least say that a follow up meeting has been arranged - the knowledge that a meeting date has been set says nothing of the outcome.
Thanks,
Waccy
Thanks Waccy,
We'll add you to the list and update you as soon as we can.
Kind regards,
Paul